SCHEMBL1744358

SCHEMBL1744358

CC(C)C(NP(=O)(Cl)Oc1cccc2cccnc12)C(=O)OCC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.42
L3MBTL1 Q9Y468 4/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
RAB9A P51151 3/20 0.40
NPC1 O15118 2/20 0.40
LMNA P02545 3/20 0.40
GAA P10253 1/20 0.40
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 2/20 0.39
HDAC6 Q9UBN7 1/20 0.39
POLB P06746 4/20 0.38
BLM P54132 1/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
MAPK1 P28482 1/20 0.38
HPGD P15428 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10208274 1.00 MAPT (0.42) MAPTL3MBTL1SMN1; SMN2RAB9ANPC1
SCHEMBL720708 0.85 L3MBTL1 (0.45) MAPTL3MBTL1SMN1; SMN2RAB9ANPC1
SCHEMBL1744377 0.85 NR3C1 (0.39) L3MBTL1SMN1; SMN2LMNAALDH1A1POLB
SCHEMBL10208250 0.83 CASP3 (0.40) SMN1; SMN2LMNAGAAALDH1A1KDM4E
SCHEMBL10208273 0.80 ALDH1A1 (0.43) MAPTSMN1; SMN2RAB9ANPC1GAA
SCHEMBL10208280 0.75 TACR3 (0.32) MAPTLMNAALDH1A1KDM4EMEN1
SCHEMBL10208297 0.75 HTT (0.38) L3MBTL1SMN1; SMN2LMNAGAAALDH1A1
SCHEMBL10208208 0.75 NR3C1 (0.39) L3MBTL1SMN1; SMN2LMNAALDH1A1POLB
SCHEMBL10208276 0.73 CXCR2 (0.34) L3MBTL1LMNAALDH1A1KDM4EKMT2A
SCHEMBL723907 0.72 HTT (0.41) L3MBTL1LMNAGAAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2385951-A2 PHOSPHORAMIDATE DERIVATIVES OF GUANOSINE NUCLEOSIDE COMPOUNDS FOR TREATMENT OF VIRAL INFECTIONS University College Cardiff Consultants, Ltd. (GB) 2011-11-16 EP disclosed
US-20110254856-A1 MOBILE TERMINAL AND METHOD OF CONTROLLING OPERATION OF THE MOBILE TERMINAL LG ELECTRONICS INC. (KR) 2011-10-20 US disclosed
WO-2010081082-A2 PHOSPHORAMIDATE DERIVATIVES OF GUANOSINE NUCLEOSIDE COMPOUNDS FOR TREATMENT OF VIRAL INFECTIONS UNIVERSITY COLLEGE OF CARDIFF CONSULTANTS LIMITED (GB) 2010-07-15 WO disclosed